Schedule 13D ownership disclosure

Emerald Bioscience, Inc.

Security class unavailable · CUSIP: 29102Y101

Event date: 2019-03-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
69.1900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001640334-19-000475
Form type
SC 13D/A
Filer
Skye Bioscience, Inc.
CIK
CIK 1516551
Filed
Apr 01, 2019
Reporting period
Mar 29, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub